Down Syndrome Research

NewsGuard 100/100 Score

Down syndrome or Down’s syndrome is a genetic condition caused by the presence of an additional copy of chromosome 21 in a person’s cells. This additional DNA causes the physical characteristics and developmental problems associated with the syndrome.

The extra copy of chromosome 21 (also referred to as trisomy 21) is acquired by chance and although Down’s syndrome is more common among babies born to mothers of an older age, mothers of any age may have a baby with the condition.

Down’s syndrome affects hundreds of babies worldwide irrespective of race, ethnicity, maternal age at conception, and social or economic class. Much research has been carried out to determine exactly how the extra chromosome 21 causes symptoms of the condition.

Research focused on the genes expressed in Down’s syndrome has led to the identification of a particular region of chromosome 21 that contains the main genes involved in the pathology of this condition. The approximate location of this region is 21q22.3 and much of the research carried out to search for key genes in Down’s syndrome involves the region 21q21–21q22.3.

Research conducted by J.R Arron et al has shown that dysregulation of transcription factors may be related to the phenotypes associated with Down’s syndrome. One of these transciption factors, NFAT, is controlled by two proteins, Down’s syndrome critical region 1 (DSCR1) and dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A).

The DSCR1 and DYRK1A genes are located on chromosome 21 and give rise to 1.5 times the usual amount of these proteins that is found in healthy cells. The high concentration of these proteins keeps NFAT mainly located in the cytoplasm rather than in the nucleus, which means NFAT is prevented from activating the transcription of certain genes. The proteins that these genes code for are therefore not produced.

Studies simulating human trisomy 21 in murine models have suggested that this dysregulation of transcription factors causes a weakened grip strength similar to the poor muscle tone observed in people with Down’s syndrome. Studies are currently ongoing to locate further genes in the Down’s syndrome critical region that may contribute to the pathology of the condition.

Sources

  1. http://www.nhs.uk/conditions/Downs-syndrome/Pages/Introduction.aspx
  2. https://ndss.org/
  3. https://www.cdph.ca.gov/
  4. https://www.nbdpn.org/
  5. https://www.dsmig.org.uk/

Further Reading

Last Updated: Jun 17, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 17). Down Syndrome Research. News-Medical. Retrieved on April 13, 2024 from https://www.news-medical.net/health/Down-Syndrome-Research.aspx.

  • MLA

    Mandal, Ananya. "Down Syndrome Research". News-Medical. 13 April 2024. <https://www.news-medical.net/health/Down-Syndrome-Research.aspx>.

  • Chicago

    Mandal, Ananya. "Down Syndrome Research". News-Medical. https://www.news-medical.net/health/Down-Syndrome-Research.aspx. (accessed April 13, 2024).

  • Harvard

    Mandal, Ananya. 2023. Down Syndrome Research. News-Medical, viewed 13 April 2024, https://www.news-medical.net/health/Down-Syndrome-Research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.